Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer
Saiers, J.H.; Slavik, M.
Veterinary and Human Toxicology 23(Suppl 1): 12-14
1981
ISSN/ISBN: 0145-6296 PMID: 6272470 Document Number: 173029
Document emailed within 1 workday
Related Documents
Fujita, A.; Takabatake, H.; Tagaki, S.; Sekine, K. 1998: Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(5): 761-764Chewaskulyong, B.; Thongprasert, S. 1998: Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer Journal of the Medical Association of Thailand 81(1): 37-41
Thongprasert, S. 2000: Phase Ii study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer Journal of the Medical Association of Thailand 83(5): 549-553
Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63
Baldini, E.; Silvano, G.; Tibaldi, C.; Campoccia, S.; Cionini, L.; Conte, P. 2000: Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase Ii study Seminars in Oncology 27(1 Suppl 1: 28-32
Johnson, D.H. 1990: Overview of ifosfamide in small cell and non-small cell lung cancer Seminars in Oncology 17(2 Suppl 4: 24-30
Shirahama, S.; Aritomi, T.; Takeo, S.; Ando, K.; Wakamatsu, S.-i.; Kumagawa, M.; Ichinose, I.; Tamura, K. 2004: Pilot study-previously treated advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(13): 2133-2137
Soh, L.T.; Tan, E.H.; Ang, P.T. 1998: Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer Singapore Medical Journal 39(8): 357-358
Mukouda, K.; Morikawa, E.; Hasegawa, K.; Noumi, K.; Ohmura, T.; Mishima, Y.; Kawamoto, M.; Inagaki, A.; Kamitsuna, A.; Yamakido, M.; Nishimoto, Y.; Koyama, T.; Katsuta, S. 1983: Ifosfamide in the treatment of small cell carcinoma of the lung Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(5): 1293-1298
Lorigan, P.; Lee, S.M.; Betticher, D.; Woodhead, M.; Weir, D.; Hanley, S.; Hardy, C.; Thatcher, N. 1995: Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer Seminars in Oncology 22(3 Suppl 7: 32-41
Perez, E.A.; Gandara, D.R. 1994: Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 2-5
Whitney, K.A.; Lysaker, P.H.; Steiner, A.R.; Hook, J.N.; Estes, D.D.; Hanna, N.H. 2008: Is"chemobrain" a transient state? a prospective pilot study among persons with non-small cell lung cancer Journal of Supportive Oncology 6(7): 313-321
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Unsal, M.; Erturk, D. 2003: Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer Saudi Medical Journal 24(6): 628-631
Abou-Mourad, Y.; Otrock, Z.K.; Makarem, J.A.; Kattan, J.G.; Farhat, F.S.; Jalloul, R.; Mokaddem, W.T.; Ghosen, M.G.; Taher, A.T.; Chehal, A.A.; Shamseddine, A.I. 2008: Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study Le Journal Medical Libanais. Lebanese Medical Journal 56(1): 16-21
Yuen, A.R.; Fuks, J.Z.; Ettinger, D.S.; Chang, A.Y.; Ruckdeschel, J.C.; Phan, S.C.; Blum, R.H. 2000: Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586) Cancer Journal From Scientific American 6(1): 34-39
Hoffman, P.C.; Masters, G.A.; Drinkard, L.C.; Krauss, S.A.; Samuels, B.L.; Golomb, H.M.; Vokes, E.E. 1996: Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies Seminars in Oncology 23(3 Suppl 6: 11-15
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Chen, Y.M.; Perng, R.P.; Yang, K.Y.; Wu, H.W.; Lin, W.C.; Liu, J.M.; Tsai, C.M.; Whang-Peng, J. 2000: Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancer Zhonghua Yi Xue Za Zhi 63(8): 605-611
Tanaka, A.; Aragane, N.; Komiya, K.; Kawaura, F.; Fukuno, Y.; Hayashi, S. 2008: A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 49-53